A new test which uses saliva to identify men with a high risk of developing prostate cancer has been devised by international researchers led by scientists at the Institute of Cancer Research, London. The DNA test which identifies the 1 per cent who are at highest risk of prostate cancer, and are also six times more likely to develop the disease than the general population. The scientists will now trial the test in 300 patients across three GP practices in London (via The Institute of Cancer Research).
This study has recently been published in Nature Genetics
In the media: